Recombinant Human LYZ Protein，His

LYZ, or lysozyme, is an enzyme that plays a critical role in the innate immune system by degrading bacterial cell walls, providing a first line of defense against microbial infections. The study of recombinant lysozyme (LYZ) has gained immense importance in both basic and applied research due to its potential applications in medicine and biotechnology. Recombination technology allows for the production of LYZ with enhanced properties, such as increased stability, antimicrobial efficacy, or altered enzymatic activity. Researchers have been exploring various expression systems, such as bacteria, yeast, and mammalian cells, to produce recombinant LYZ at scale. Furthermore, the understanding of LYZ's structure-function relationship has been pivotal for engineering variants with specific attributes, addressing challenges like antibiotic resistance in pathogens. Additionally, recombinant LYZ is being investigated for its usefulness in food preservation, agriculture, and therapeutic applications, including its use as a potential antimicrobial agent in treatments. The growing interest in biopharmaceuticals and functional foods underscores the significance of LYZ research, as it opens avenues for innovative solutions to combat bacterial infections and enhance food safety. Overall, the study of recombinant lysozyme represents a convergence of microbiology, molecular biology, and biotechnology, with implications that extend across healthcare and food industries.